Neogene: AstraZeneca completes acquisition of Neogene Therapeutics

(marketscreener.com) AstraZeneca PLC on Monday said it completed its acquisition of Neogene Therapeutics Inc, a clinical-stage biotechnology company focused on the discovery, development and manufacturing of T-cell receptor therapies. Neogene Therapeutics now will operate as a wholly-owned subsidiary of the Cambridge-based pharmaceutical company, with operations in...https://www.marketscreener.com/quote/stock/ASTRAZENECA-PLC-4000930/news/AstraZeneca-completes-acquisition-of-Neogene-Therapeutics-42739987/?utm_medium=RSS&utm_content=20230116